e-learning
resources
Madrid 2019
Monday, 30.09.2019
Phenotypes and endotypes of bronchiectasis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pseudomonas aeruginosa as an independent predictor of decreased lung function in bronchiectasis
J. Cordeiro Da Costa (Leiria, Portugal), R. Viana (Leiria, Portugal), C. Gonçalves Silva (Leiria, Portugal), C. Carvalho (Leiria, Portugal), S. Feijó (Leiria, Portugal)
Source:
International Congress 2019 – Phenotypes and endotypes of bronchiectasis
Session:
Phenotypes and endotypes of bronchiectasis
Session type:
Thematic Poster
Number:
2871
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Cordeiro Da Costa (Leiria, Portugal), R. Viana (Leiria, Portugal), C. Gonçalves Silva (Leiria, Portugal), C. Carvalho (Leiria, Portugal), S. Feijó (Leiria, Portugal). Pseudomonas aeruginosa as an independent predictor of decreased lung function in bronchiectasis. 2871
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
The effect of Pseudomonas aeruginosa on pulmonary function in patients with bronchiectasis
Source: Eur Respir J 2006; 28: 974-979
Year: 2006
The independent contribution of
Pseudomonas aeruginosa
infection to long-term clinical outcomes in bronchiectasis
Source: Eur Respir J, 51 (2) 1701953; 10.1183/13993003.01953-2017
Year: 2018
Factors associated with infection by Pseudomonas aeruginosa in adult cystic fibrosis
Source: Eur Respir J 2005; 26: 651-656
Year: 2005
Increased airway iron as a potential factor in the persistence of Pseudomonas aeruginosa infection in cystic fibrosis
Source: Eur Respir J 2007; 30: 286-292
Year: 2007
Pseudomonas aeruginosa adaptation and diversification in the non-cystic fibrosis bronchiectasis lung
Source: Eur Respir J , 49 (4) 1602108; DOI: 10.1183/13993003.02108-2016
Year: 2017
Does a single Pseudomonas aeruginosa isolation predict COPD mortality?
Source: Eur Respir J 2014; 44: 794-797
Year: 2014
Evaluating the Leeds criteria for Pseudomonas aeruginosa infection in a cystic fibrosis centre
Source: Eur Respir J 2006; 27: 937-943
Year: 2006
Variability of ß-lactamase resistance Pseudomonas aeruginosa genes infecting patients with cystic fibrosis
Source: Virtual Congress 2021 – Back to infection basics
Year: 2021
Chronic but not intermittent infection with
Pseudomonas aeruginosa
is associated with global changes of the lung microbiome in cystic fibrosis
Source: Eur Respir J, 50 (4) 1701086; 10.1183/13993003.01086-2017
Year: 2017
Does sputum induction improve
Pseudomonas aeruginosa
detection in cystic fibrosis?
Source: Eur Respir J 2003; 22: Suppl. 45, 231s
Year: 2003
Epidemiological-molecular study of colonization by pseudomonas aeruginosa in cystic fibrosis patients
Source: Eur Respir J 2002; 20: Suppl. 38, 379s
Year: 2002
Persistence and genetic adaptation of Pseudomonas aeruginosa in patients with COPD.
Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond
Year: 2020
Omics-based tracking of
Pseudomonas aeruginosa
persistence in “eradicated” cystic fibrosis patients
Source: Eur Respir J, 57 (4) 2000512; 10.1183/13993003.00512-2020
Year: 2021
Inflammatory markers in cystic fibrosis patients with transmissible Pseudomonas aeruginosa
Source: Eur Respir J 2003; 22: 503-506
Year: 2003
Bacterial cyanogenesis occurs in the cystic fibrosis lung
Source: Eur Respir J 2008; 32: 329-333
Year: 2008
Pseudomonas aeruginosa in the home environment of newly infected cystic fibrosis patients
Source: Eur Respir J 2008; 31: 822-829
Year: 2008
Burkholderia cepacia infection in adult cystic fibrosis patients: Its impact on lung function and survival
Source: Annual Congress 2010 - New aspects of cystic fibrosis
Year: 2010
Sputum versus bronchoscopy for diagnosis of Pseudomonas aeruginosa biofilms in cystic fibrosis
Source: Eur Respir J 2004; 24 : 631-637
Year: 2004
Predicting the outcome of respiratory Pseudomonas aeruginosa infection in vivo
Source: International Congress 2017 – Cystic fibrosis: treatments and monitoring
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept